These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3031148)

  • 1. Isolation of the C1r sub-unit of the first complement component (C1), avoiding low pH values.
    Weiner EM
    J Biochem Biophys Methods; 1986 Dec; 13(6):347-50. PubMed ID: 3031148
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification of subcomponents Clq, Cl(-)r and Cl(-)s of the first component of complement from Cohn Fraction I by affinity chromatography.
    Bing DH; Andrews JM; Morris KM; Cole E; Irish V
    Prep Biochem; 1980; 10(3):269-96. PubMed ID: 6251443
    [No Abstract]   [Full Text] [Related]  

  • 3. A rapid and efficient method for the purification of the complement subcomponents C1r and C1s in zymogen form using fast protein chromatography.
    Peitsch MC; Kovacsovics TJ; Isliker H
    J Immunol Methods; 1988 Apr; 108(1-2):265-9. PubMed ID: 2832479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reconstitution of human C1, the first complement component: binding of C1r and C1s to C1q influences the C1q conformation.
    Golan MD; Hitschold T; Loos M
    FEBS Lett; 1981 Jun; 128(2):281-5. PubMed ID: 6266874
    [No Abstract]   [Full Text] [Related]  

  • 5. Component deficiencies. 1. The first component: C1q, C1r, C1s.
    Loos M; Heinz HP
    Prog Allergy; 1986; 39():212-31. PubMed ID: 3031693
    [No Abstract]   [Full Text] [Related]  

  • 6. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
    Bauer J; Valet G
    Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production of purified C1q-component of complement and its characteristics].
    Nedugova GI; Rubtsov IV
    Lab Delo; 1987; (7):542-7. PubMed ID: 2442491
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of a complex of C1r and C1s subcomponents of human complement C1 by the third subcomponent C1q.
    Lin TY; Fletcher DS
    J Biol Chem; 1980 Aug; 255(16):7756-62. PubMed ID: 6249812
    [No Abstract]   [Full Text] [Related]  

  • 11. Human complement component C1s. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation.
    Spycher SE; Nick H; Rickli EE
    Eur J Biochem; 1986 Apr; 156(1):49-57. PubMed ID: 3007145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium binding properties of the C1 subcomponents C1q, C1r and C1s.
    Villiers CL; Arlaud GJ; Painter RH; Colomb MG
    FEBS Lett; 1980 Aug; 117(1):289-94. PubMed ID: 6250896
    [No Abstract]   [Full Text] [Related]  

  • 13. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
    McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
    Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the first component of complement.
    Schumaker VN; Zavodszky P; Poon PH
    Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
    [No Abstract]   [Full Text] [Related]  

  • 16. A monoclonal antibody to C1q which appears to interact with C1r2C1s2-binding site.
    Hsiung L; Dodds AW; Mason DW; Reid KB
    FEBS Lett; 1988 Feb; 229(1):21-4. PubMed ID: 2831088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dissociation properties of native C1.
    Ziccardi RJ; Tschopp J
    Biochem Biophys Res Commun; 1982 Jul; 107(2):618-23. PubMed ID: 6289835
    [No Abstract]   [Full Text] [Related]  

  • 18. NH2-terminal calcium-binding domain of human complement C1s- mediates the interaction of C1r- with C1q.
    Busby TF; Ingham KC
    Biochemistry; 1990 May; 29(19):4613-8. PubMed ID: 2372546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of C1q, factor B, factor D and properdin in healthy children, and the age-related presence of circulating C1r-C1s complexes.
    Prellner K; Sjöholm AG; Truedsson L
    Acta Paediatr Scand; 1987 Nov; 76(6):939-43. PubMed ID: 2827430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.